Looking into Axonics Modulation Tech's Return on Capital Employed

After pulling data from Benzinga Pro it seems like during Q2, Axonics Modulation Tech AXNX posted sales of $45.87 million. Earnings were up 25.93%, but Axonics Modulation Tech still reported an overall loss of $16.01 million. In Q1, Axonics Modulation Tech brought in $34.37 million in sales but lost $21.62 million in earnings.

What Is Return On Capital Employed?

Changes in earnings and sales indicate shifts in Axonics Modulation Tech's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, Axonics Modulation Tech posted an ROCE of -0.03%.

It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.

Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.

For Axonics Modulation Tech, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.

Upcoming Earnings Estimate

Axonics Modulation Tech reported Q2 earnings per share at $-0.59/share, which did not meet analyst predictions of $-0.49/share.